Qualitative risk assessment of follicle stimulating hormone injectable products.
Douglas T SteinkeOsman H ZarrougRaj MathurHelen KendrewJulian JenkinsPublished in: Expert opinion on drug delivery (2020)
The study identifies differences in the risks for both sharps injuries and dosing errors between FSH delivery options that practitioners should consider when making a treatment choice.